Guangxi Huaxi Nonferrous Metal Co.,Ltd (SHA:600301)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,834	10,760	7,958	2,998	2,975	1,573
Market Cap Growth	56.10%	35.22%	165.42%	0.79%	89.09%	-2.76%
Enterprise Value	15,080	11,853	9,349	2,843	2,842	1,413
Last Close Price	21.87	17.01	12.58	12.75	12.65	6.69
PE Ratio	20.49	16.36	22.71	13.71	55.38	48.46
PS Ratio	2.86	2.32	2.49	1.08	7.55	1.74
PB Ratio	2.80	2.16	1.67	0.90	9.31	3.69
P/TBV Ratio	8.81	7.71	6.09	-	9.36	3.69
P/FCF Ratio	14.23	9.58	9.97	5.22	-	8.84
P/OCF Ratio	12.50	8.70	8.70	4.35	-	8.14
EV/Sales Ratio	3.12	2.56	2.92	1.03	7.21	1.57
EV/EBITDA Ratio	9.44	7.59	9.05	3.64	61.37	36.61
EV/EBIT Ratio	11.37	9.12	11.91	4.73	67.04	39.73
EV/FCF Ratio	15.51	10.56	11.71	4.95	-	7.94
Debt / Equity Ratio	0.31	0.26	0.27	0.68	0.03	-
Debt / EBITDA Ratio	0.94	0.81	1.25	2.89	0.17	-
Debt / FCF Ratio	1.55	1.13	1.63	3.95	-	-
Asset Turnover	0.67	0.62	0.46	0.78	0.81	1.95
Inventory Turnover	4.39	4.72	5.45	-	-	-
Quick Ratio	0.76	0.75	0.56	0.52	2.67	5.72
Current Ratio	1.35	1.19	0.79	0.74	3.57	5.75
Return on Equity (ROE)	23.61%	21.80%	14.75%	23.70%	14.41%	8.67%
Return on Assets (ROA)	11.41%	10.86%	7.08%	10.61%	5.46%	4.81%
Return on Capital (ROIC)	13.71%	13.18%	8.40%	12.65%	7.03%	5.93%
Return on Capital Employed (ROCE)	21.40%	21.90%	15.50%	13.20%	12.80%	8.10%
Earnings Yield	4.87%	6.11%	4.40%	7.29%	1.81%	2.06%
FCF Yield	7.03%	10.44%	10.04%	19.15%	-3.76%	11.32%
Payout Ratio	33.87%	18.72%	19.28%	48.05%	12.39%	-
Buyback Yield / Dilution	-27.96%	-2.16%	-4.76%	-153.05%	-0.71%	-6.96%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.